Handgrip Strength in Chronic Obstructive Pulmonary Disease: Ready for Prime Time or Frailty Research Tool?

2017 ◽  
Vol 14 (11) ◽  
pp. 1630-1631
Author(s):  
Cassie C. Kennedy
2021 ◽  
Vol 8 (4) ◽  
pp. 1
Author(s):  
Jozélio Freire De Carvalho ◽  
Aaron Lerner

Objective: To describe a patient with presarcopenia and chronic cough secondary to chronic obstructive pulmonary disease (COPD) successfully treated with supplements and physical exercise.Case report: A 75-year-old female patient with a positive past medical history of systemic hypertension, dyslipidemia, heart arrhythmia, and smoking during 20 years evolved with chronic cough due to a chronic obstructive pulmonary disease diagnosed ten years ago. She came to our private clinic due to low weight, low energy. Her weight was 44.8 kg, her height 1.57 m, body mass index of 18.18 kg/m2. Laboratory tests showed SDHEA 76.3, vitamin D of 15.6 ng/ml (nr: > 30 ng/ml), C-reactive protein (CRP) of 55 mg/ml. Computed tomography showed bronchiectasis. She had an skeletal muscle mass index of 5.0 kg/m2 (nr: > 5.5 kg/m2) by DXA. A diagnosis of presarcopenia was determined based on DXA evaluation with low muscle mass but normal gait speed handgrip strength. We suggested to the patient to increase physical exercise and prescribed a supplement formula. After five months, she returned asymptomatic, without cough, marked improvement of fatigue, increased energy levels, and weight increased to 50 kg, BMI of 20.28 kg/m2. Laboratory tests showed SDHEA to 140, vitamin D3 to 64.5 ng/ml, reduced CRP reduced to 5 mg/dl, and amlodipine was excluded due to better blood pressure control. Currently, two years later, the patient continues without cough and has dyspnea only with high efforts, without fatigue, and her weight is 52 kg and BMI 21.1 kg/m2. She also reduced her conventional treatment for COPD, using only a bronchodilator on-demand, without topical corticoids.Conclusions: This case illustrates an interesting case of a patient with presarcopenia and chronic cough, refractory to conventional approach, successfully treated with a combination of nutraceuticals and physical exercises.


Author(s):  
Anne-Kathrin Rausch-Osthoff ◽  
Malcolm Kohler ◽  
Noriane A. Sievi ◽  
Christian F. Clarenbach ◽  
Arnoldus J.R. Van Gestel

Background: Resistance training of peripheral muscles has been recommended in order to increase muscle strength in patients with Chronic Obstructive Pulmonary Disease (COPD). However, whether peripheral muscle strength is associated with exercise performance (EP) and physical activity in daily life (PADL) in these patients needs to be investigated. The aim of this study is to evaluate whether strength of the quadriceps muscle (QS) is associated with EP and daily PADL in patients with COPD. Methods: We studied patients with COPD (GOLD A-D) and measured maximal isometric strength of the left QS. PADL was measured for 7 days with a SenseWear-Pro® accelerometer. EP was quantified by the 6-minute walk distance (6MWD), the number of stands in the Sit-to-Stand Test (STST), and the handgrip-strength. Univariate and multivariate analyses were used to examine possible associations between QS, PADL and EP. Results: In 27 patients with COPD with a mean (SD) FEV1 of 37.6 (17.6)% predicted, QS was associated with 6MWD, STST, and handgrip-strength but not with PADL. Multiple linear regression analyses showed that QS was independently associated with the 6MWD (β = 0.42, 95% CI 0.09 to 0.84, p = 0.019), STST (β = 0.50, 95% CI 0.11 to 0.86, p = 0.014) and with handgrip-strength (β = 0.45, 95% CI 0.05 to 0.84, p = 0.038). Conclusions: Peripheral muscle strength may be associated with exercise performance but not with physical activity in daily life. This may be due to the fact that EP tests evaluate patients’ true abilities while PADL accelerometers may not.


2019 ◽  
Vol 8 (7) ◽  
pp. 946 ◽  
Author(s):  
Francesc Medina-Mirapeix ◽  
Roberto Bernabeu-Mora ◽  
Maria Piedad Sánchez-Martínez ◽  
Mariano Gacto-Sánchez ◽  
Rodrigo Martín San Agustín ◽  
...  

Recent recommendations for chronic obstructive pulmonary disease (COPD) suggest that evaluation and management should focus on patient health status. Despite the frequency of poor health status and its negative impact on patients with COPD, little is known about how poor or non-poor health status persists and/or remits over time or what factors might predict recovery from a poor health status. The aim was to determine the likelihood of transitioning between poor and non-poor health status in patients with stable COPD followed for 2 years and to investigate factors that might predict recovery from poor health status. We prospectively included 137 patients with stable COPD (mean age, 66.9 years ± 8.3). Health status was measured at baseline and after 1 and 2 years with the COPD assessment test (CAT). Higher scores indicated worse health status, and 10 was the cut-off score for discriminating between non-poor and poor health status. The likelihoods of annual transitions to new episodes and recovery were calculated. We evaluated demographic, non-respiratory, and respiratory variables as potential predictors with generalized estimating equations. At baseline, 37 patients (27%) reported non-poor health status. Within the group of patients displaying poor health status at the beginning of the year, 176 annual transitions were identified during the study period: 15.9% were transitions to recovery from poor health status. In contrast, of the 70 transitions from a starting non-poor health status, 32.4% worsened. Predictors of transitions to recovery were: current non-smoker status (odds ratio (OR) = 3.88; 95% confidence interval (CI): 0.64–5.54) and handgrip strength (OR = 1.08; 95% CI: 1.00–1.16). This study suggests that self-reported health status, measured with the CAT, has a dynamic nature in patients with COPD. Annual transitions towards recovery from poor health status are most likely among current non-smoking patients and those with high handgrip strength.


2021 ◽  
Vol 25 (2) ◽  
pp. 67-75
Author(s):  
Thi Thu Huong Nguyen ◽  
Trung Anh Nguyen ◽  
Thi Diu Vu ◽  
Thi Thanh Huyen Vu

Objectives: To determine the rate and characteristics of sarcopenia in older patients with stable chronic obstructive pulmonary disease. Subjects and methods: a cross-sectional descriptive study on 363 stable chronic obstructive pulmonary disease (COPD) patients aged ≥ 60 years old examined and treated at the National Geriatrics Hospital and 19-8 Hospital. Study subjects were measured appendicular skeletal muscle with dual energy adsorption radiographs and diagnosed with sarcopenia based on the criteria of Asian Working Group for sarcopenia – AWGS. Results: Average age of study subjects was 70.7 ± 8.3 (years), male rate was 60.3%. The prevalence of sarcopenia in the study group was 45.2%. 74.6% of patients had a decrease in total appendicular skeletal muscle according to height (ASMI), 68.3% had a decrease in handgrip strength (HGS) and 42.7% had a decrease in walking speed. The ASMI, handgrip strength and walking speed decreased with age. Conclusion: The study highlighted a high rate of sarcopenia (45.2%) in elderly patients with stable stage COPD. The ASMI, handgrip strength and walking speed decreased with age. Therefore, it is necessary to screening and early diagnosis of sarcopenia in elderly COPD patients.


2017 ◽  
Vol 15 (3) ◽  
pp. 250-257 ◽  
Author(s):  
Panita Limpawattana ◽  
Pratchaya Inthasuwan ◽  
Siraphong Putraveephong ◽  
Watchara Boonsawat ◽  
Daris Theerakulpisut ◽  
...  

Chronic obstructive pulmonary disease (COPD) has been described as a systemic disease. Sarcopenia is one of the systemic effects that is related to several adverse outcomes. The objectives of this study were to estimate the prevalence of sarcopenia and to determine the factors associated with sarcopenia in COPD patients in Southeast Asia. This was a cross-sectional study of COPD patients who attended a COPD clinic from May 2015 to December 2016. Baseline characteristics were collected and dual-energy X-ray absorptiometry was used to measure skeletal muscle mass. Handgrip strength was used to assess muscle strength, and as a measurement of physical performance, the 6-min walk distance was used. One hundred and twenty-one participants were recruited. Most of them were men (92.6%). Prevalence of sarcopenia was 24% (29 cases). Independent factors associated with sarcopenia were age ≥ 75 years (adjusted odds ratio (AOR) 13.3, severity of COPD (AOR 19.2 and 13.4 for moderate and severe COPD), Modified Medical Research Council (MMRC) scale (AOD 1.9), and obesity (AOR 0.04). Sarcopenia affects about one-quarter of COPD patients. Age, severity of COPD, MMRC scale, and BMI status were the factors associated with sarcopenia.


Author(s):  
Jéssica Fonseca ◽  
Felipe Vilaça Cavallari Machado ◽  
Laís Carolini Santin ◽  
Ana Carolina Andrello ◽  
Lorena Paltanin Schneider ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document